Form D · Pharmaceuticals
GridAI Technologies Corp.
Boca Raton, FL · CIK 0001604191
Offering snapshot reported Jul 15, 2026 · SEC filing
- Reported sold
- $8.5M Offering amount: $8.5M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 1, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 15, 2026 | Initial | $8,500,000 | No comparison | 6 | SEC filing |
| May 27, 2026 | Initial | $5,250,000 | No comparison | 4 | SEC filing |
| May 27, 2026 | Initial | $2,540,000 | No comparison | 4 | SEC filing |
| Aug 18, 2025 | Initial | $3,025,000 | No comparison | 3 | SEC filing |
| Sep 21, 2023 | Initial | $1,470,509 | No comparison | 1 | SEC filing |
| Jun 28, 2023 | Initial | $431,083 | No comparison | 1 | SEC filing |
| Mar 23, 2023 | Initial | $4,000,001 | No comparison | 1 | SEC filing |
| Dec 1, 2022 | Initial | $2,500,001 | No comparison | 1 | SEC filing |
| Jul 26, 2022 | Initial | $300,000 | No comparison | 2 | SEC filing |
| Jul 31, 2020 | Initial | $22,426,890 | No comparison | 177 | SEC filing |
| Jan 17, 2020 | Initial | $6,904,000 | No comparison | 70 | SEC filing |
| Mar 1, 2019 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| Jun 15, 2017 | Initial | $5,000,000 | No comparison | 27 | SEC filing |
| Apr 21, 2017 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Apr 11, 2016 | Initial | $635,000 | No comparison | 4 | SEC filing |
| Nov 3, 2014 | Initial | $284,000 | No comparison | 3 | SEC filing |
| Apr 2, 2014 | Initial | $385,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-590934
5% of the gross proceeds will be paid to the Company at closing. The remaining 95% of the proceeds will be paid prior to the declaration by the SEC that the Registration Statement is effective.
Source: Form D, filed Jul 15, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matthew Balk | Promoter |
| Ed Borkowski | Director |
| Edward Borkowski | Director |
| Charles Casamento | Director |
| Terry Coelho | Director |
| Eric Corbett | Director |
| Daniel Dupret | Executive |
| David Hoffman | Director |
| Gregory Oakes | Director |
| Richard Paolone | Director, Executive |
| James Lee Pennington | Executive |
| Geordan Pursglove | Director |
| Alastair Riddell | Director |
| Christine Rigby | Executive |
| Sarah Romano | Executive |
| James Sapirstein | Director, Executive |
| Jason Sawyer | Director, Executive |
| Daniel Schneiderman | Executive |
| Vern Lee Schramm | Director |
| Maged Shenouda | Director, Executive |
| Anna Skowron | Executive |
| Johan Spoor | Director, Executive |
| Johan (Thijs) Spoor | Director, Executive |
| Jack Syage | Director |
| Manpreet Uppal | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
433 Plaza Real, Suite 275
Boca Raton, FL, 33432
Boca Raton, FL, 33432